These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 36305091
1. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. Xie X, Gu J, Zhuang D, Zhou Y, Chen X, Shen W, Li L, Liu Y, Xu W, Hong Q, Xu Z, Chen W, Zhou W, Liu H. J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091 [Abstract] [Full Text] [Related]
2. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review. Oueslati B, Moula O, Ghachem R. Pharmacogenomics; 2018 Jun 01; 19(8):741-747. PubMed ID: 29785888 [Abstract] [Full Text] [Related]
3. The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment. Levran O, Peles E, Randesi M, da Rosa JC, Adelson M, Kreek MJ. Pharmacogenomics; 2017 Oct 01; 18(15):1387-1391. PubMed ID: 28976288 [Abstract] [Full Text] [Related]
4. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. Chen YT, Tsou HH, Kuo HW, Fang CP, Wang SC, Ho IK, Chang YS, Chen CH, Hsiao CF, Wu HY, Lin KM, Chen ACh, Tsai-Wu JJ, Liu YL. J Hum Genet; 2013 Feb 01; 58(2):84-90. PubMed ID: 23223006 [Abstract] [Full Text] [Related]
5. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Haerian BS, Haerian MS. Pharmacogenomics; 2013 May 01; 14(7):813-24. PubMed ID: 23651028 [Abstract] [Full Text] [Related]
6. Association study of genetic polymorphisms in GABRD with treatment response and dose in methadone maintenance treatment. Xie X, Gu J, Zhuang D, Chen X, Zhou Y, Shen W, Li L, Liu Y, Xu W, Hong Q, Chen W, Zhou W, Liu H. Per Med; 2021 Sep 01; 18(5):423-430. PubMed ID: 34160285 [Abstract] [Full Text] [Related]
7. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. Zhang Q, Shi M, Tang H, Zhong H, Lu X. Genet Test Mol Biomarkers; 2020 Jan 01; 24(1):17-23. PubMed ID: 31940240 [Abstract] [Full Text] [Related]
8. Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Hancock DB, Levy JL, Gaddis NC, Glasheen C, Saccone NL, Page GP, Hulse GK, Wildenauer D, Kelty EA, Schwab SG, Degenhardt L, Martin NG, Montgomery GW, Attia J, Holliday EG, McEvoy M, Scott RJ, Bierut LJ, Nelson EC, Kral AH, Johnson EO. Biol Psychiatry; 2015 Oct 01; 78(7):474-84. PubMed ID: 25744370 [Abstract] [Full Text] [Related]
9. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. Wang SC, Tsou HH, Chen CH, Chen YT, Ho IK, Hsiao CF, Chou SY, Lin YF, Fang KC, Huang CL, Su LW, Fang YC, Liu ML, Wu HY, Lin KM, Liu SC, Kuo HW, Chiang IC, Chen AC, Tian JN, Liu YL. Eur Neuropsychopharmacol; 2012 Oct 01; 22(10):695-703. PubMed ID: 22406240 [Abstract] [Full Text] [Related]
10. OPRM1 and CYP3A4 association with methadone dose in Iranian patients undergoing methadone maintenance therapy. Akbari A, Kheradmand A, Sina M, Ahmadiani A, Asadi S. J Addict Dis; 2021 Oct 01; 39(3):357-362. PubMed ID: 33682628 [Abstract] [Full Text] [Related]
11. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL. Behav Genet; 2016 Mar 01; 46(2):151-69. PubMed ID: 26392368 [Abstract] [Full Text] [Related]
12. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study. Takemura M, Niki K, Okamoto Y, Kawamura T, Kohno M, Matsuda Y, Ikeda K. J Pain Symptom Manage; 2024 Jan 01; 67(1):39-49.e5. PubMed ID: 37757956 [Abstract] [Full Text] [Related]
13. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population. Kumar D, Chakraborty J, Das S. Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar 30; 36(2):225-30. PubMed ID: 22138325 [Abstract] [Full Text] [Related]
14. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions. Xu J, Lu Z, Xu M, Pan L, Deng Y, Xie X, Liu H, Ding S, Hurd YL, Pasternak GW, Klein RJ, Cartegni L, Zhou W, Pan YX. J Neurosci; 2014 Aug 13; 34(33):11048-66. PubMed ID: 25122903 [Abstract] [Full Text] [Related]
15. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes. Fonseca F, Gratacòs M, Escaramís G, De Cid R, Martín-Santos R, Fernández-Espejo E, Estivill X, Torrens M. Mol Diagn Ther; 2010 Jun 01; 14(3):171-8. PubMed ID: 20560679 [Abstract] [Full Text] [Related]
16. No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. Nikolov MA, Beltcheva O, Galabova A, Ljubenova A, Jankova E, Gergov G, Russev AA, Lynskey MT, Nelson EC, Nesheva E, Krasteva D, Lazarov P, Mitev VI, Kremensky IM, Kaneva RP, Todorov AA. Drug Alcohol Depend; 2011 Aug 01; 117(1):62-5. PubMed ID: 21277709 [Abstract] [Full Text] [Related]
17. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Shi J, Hui L, Xu Y, Wang F, Huang W, Hu G. Hum Mutat; 2002 Apr 01; 19(4):459-60. PubMed ID: 11933204 [Abstract] [Full Text] [Related]
18. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment. Tolami HF, Sharafshah A, Tolami LF, Keshavarz P. J Mol Neurosci; 2020 Apr 01; 70(4):504-513. PubMed ID: 31853823 [Abstract] [Full Text] [Related]
19. A novel tetra-primer ARMS-PCR for genotyping of the OPRM1 gene rs1799971 variant associated with opioid use disorders. Wijekumar PJ, Ranadeva NDK, Jayamaha AR, Herath HMNDM, Noorden N, Fernando SSN. BMC Res Notes; 2023 Nov 14; 16(1):333. PubMed ID: 37964305 [Abstract] [Full Text] [Related]
20. Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies. Kong X, Deng H, Gong S, Alston T, Kong Y, Wang J. BMC Med Genet; 2017 Oct 26; 18(1):120. PubMed ID: 29070014 [Abstract] [Full Text] [Related] Page: [Next] [New Search]